This company has been marked as potentially delisted and may not be actively trading. SpringWorks Therapeutics (SWTX) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock SpringWorks Therapeutics Earnings Summary SpringWorks Therapeutics posted Q1 2025 earnings on May 9, 2025, reporting an EPS of -$1.11, which missed analysts' consensus estimates of -$0.81 by $0.30. Quarterly revenue was reported to be $49.09 million, below analysts' expectations of $64.19 million. With a trailing EPS of -$3.41, SpringWorks Therapeutics' earnings are expected to grow next year, from ($2.05) to ($0.13) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q)Powered by Latest Q1 Earnings DateMay. 9EstimatedConsensus EPS (May. 9) -$0.81 Actual EPS (May. 9) -$1.11 Missed By -$0.30 Actual Revenue (May. 9) $49.09M Get SpringWorks Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SpringWorks Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSWTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SWTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. SpringWorks Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.84-$0.71-$0.78Q2 20252-$0.78-$0.60-$0.69Q3 20252-$0.67-$0.50-$0.59Q4 20252-$0.53-$0.39-$0.46 SpringWorks Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/9/2025Q1 2025-$0.81-$1.11 -$0.30-$1.11$64.19M$49.09M2/20/2025Q4 2024-$0.66-$1.04 -$0.38-$1.04$60.53M$61.55M11/12/2024Q3 2024-$0.75-$0.72+$0.03-$0.72$53.28M$49.10M8/7/2024Q2 2024-$1.12-$0.54+$0.58-$0.54$34.42M$59.73M5/2/2024Q1 2024-$1.17-$1.18 -$0.01-$1.18$12.07M$21.00M2/27/2024Q4 2023-$1.24-$1.44 -$0.20-$1.44$1.26M$5.45M11/2/2023Q3 2023-$1.31-$1.27+$0.04-$1.27-- SpringWorks Therapeutics Earnings - Frequently Asked Questions When did SpringWorks Therapeutics announce their last quarterly earnings? SpringWorks Therapeutics (NASDAQ:SWTX) last announced its quarterly earning data on Friday, May 9, 2025. Learn more on SWTX's earnings history. Did SpringWorks Therapeutics beat their earnings estimates last quarter? In the previous quarter, SpringWorks Therapeutics (NASDAQ:SWTX) missed the analysts' consensus estimate of ($0.81) by $0.30 with a reported earnings per share (EPS) of ($1.11). Learn more on analysts' earnings estimate vs. SWTX's actual earnings. How much revenue does SpringWorks Therapeutics generate each year? SpringWorks Therapeutics (NASDAQ:SWTX) has a recorded annual revenue of $191.59 million. How much profit does SpringWorks Therapeutics generate each year? SpringWorks Therapeutics (NASDAQ:SWTX) has a recorded net income of -$258.13 million. SWTX has generated -$3.41 earnings per share over the last four quarters. What is SpringWorks Therapeutics' EPS forecast for next year? SpringWorks Therapeutics' earnings are expected to grow from ($2.05) per share to ($0.13) per share in the next year. More Earnings Resources from MarketBeat Related Companies Genmab A/S Earnings Results Dr. Reddy's Laboratories Earnings Results Qiagen Earnings Results Moderna Earnings Results Ascendis Pharma A/S Earnings Results Viatris Earnings Results BridgeBio Pharma Earnings Results Verona Pharma PLC American Depositary Share Earnings Results Blueprint Medicines Earnings Results Roivant Sciences Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Dutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a RallyRivian Takes Earnings Hit—R2 Could Be the Stock's 2026 Lifeline This page (NASDAQ:SWTX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
